Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-only induction versus usual care for emergency ICU tracheal intubation
ACTRN12624001418561Phase 3Recruiting
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketamine in critical illness (2 arms), sponsored by St Vincent's Hospital Melbourne. Primary endpoints: Area under mean arterial pressure less than 65 mmHg curve and Feasibility of multicentre trial enrollment. Started Mar 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
critical illness
Beyond the preview
Go deeper on ACTRN12624001418561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001418561.